Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in Uganda: Correlation with polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes

American Journal of Tropical Medicine and Hygiene

Volumn 61, Issue 3, 1999, Pages 463-466

  Jelinek, T ^a   Kilian, A H D ^b   Kabagambe, G ^c   Von Sonnenburg, F ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b Basic Health Services   (Uganda)

^c District Health Services   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; FANSIDAR;

ALLELISM; ANTIBIOTIC RESISTANCE; ARTICLE; CODON; DNA POLYMORPHISM; DRUG SENSITIVITY; GENE MUTATION; GENE SEQUENCE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; NONHUMAN; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; UGANDA;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 0032842337     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1999.61.463     Document Type: Article

References (26)

1. Peterson D, Walliker D, Wellems T, 1988. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc Natl Acad Sci USA 85: 9114-9118.
2. Triglia T, Wang P, Sims PF, Hyde JE, Cowman AF, 1998. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. EMBO J 17: 3807-3815.
3. Triglia T, Menting J, Wilson C, Cowman A, 1997. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 94: 13944-13949.
4. Triglia T, Cowman AF, 1994. Primary structure and expression of the dihydropteroate synthetase gene of Plasmodium falciparum. Proc Natl Acad Sci USA 91: 7149-7153.
5. Brooks D, Wang P, Read M, Watkin W, Sims P, Hyde J, 1994. Sequence variation in the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthetase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem 224: 397-405.
6. Wang P, Reed M, Sims P, Hyde J, 1997. Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization. Mol Microbiol 23: 979-986.
7. Wang P, Brooks DR, Sims PF, Hyde JE, 1995. A mutation-specific PCR system to detect sequence variation in the dihydropteroate synthetase gene of Plasmodium falciparum. Mol Biochem Parasitol 71: 115-125.
8. Clyde D, 1954. Observations on monthly pyrimethamine ("Daraprim") prophylaxis in an east African village. East Afr Med J 3: 41-46.
9. Clyde D, Shute G, 1957. Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals. Trans R Soc Trop Med Hyg 51: 505-513.
10. Ndyomugyenyi R, Magnussen P, 1997. In vivo sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine-pyrimethamine in school children in Hoima district, western Uganda. Acta Trop 66: 137-143.
11. Nevill CG, Ochen K, Munafu CG, Bekobita D, Sezi CL, 1995. Response of Plasmodium falciparum to chloroquine and Fansidar in vivo and chloroquine and amodiaquine in vitro in Uganda. East Afr Med J 72: 349-354.
12. Kamugisha J, Kipp W, Burnham G, 1994. In vivo sensitivity of Plasmodium falciparum to chloroquine, amodiaquine and sulfadoxine-pyrimethamine in western Uganda. Trop Geogr Med 46: 364-365.
13. Anonymous, 1996. Assessment of the Therapeutic Efficacy of Antimalarial Drugs for Uncomplicated Falciparum Malaria in Areas with Intense Transmission. Geneva: World Health Organization. WHO/MAL/96.1077.
14. Wooden J, Kyes S, Sibley C, 1993. PCR and strain identification in Plasmodium falciparum. Parasitol Today 9: 303-305.
15. Jelinek T, Pröll S, Hess F, von Sonnenburg F, Kabagambe K, Löscher T, Kilian AHD, 1996. Geographical differences in the sensitivity of polymerase chain reaction for detection of Plasmodium falciparum infection in Uganda. Am J Trop Med Hyg 55: 647-651.
16. Pääbo S, 1990. Amplifying ancient DNA. Innis M, Gelfand D, Sninsky J, White T, eds. PCR Protocols. London: Academic Press, 159-166.
17. Jelinek T, Rønn A, Curtis J, Duraisingh M, Lemnge M, Mhina J, Bygbjerg I, Warhurst D, 1997. High prevalence of mutations in the dihydrofolate reductase gene of Plasmodium falciparum in isolates from Tanzania without association to clinical resistance to sulfadoxine/pyrimethamine. Trop Med Int Health 2: 1075-1079.
18. Jelinek T, Rønn AM, Lemnge MM, Curtis J, Mhina J, Duraisingh MT, Bygbjerg IC, Warhurst DC, 1998. Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania. Trop Med Int Health 3: 605-609.
19. Foote S, Galatis D, Cowman A, 1990. Amino acids in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum involved in cycloguanil resistance differ from those involved in pyrimethamine resistance. Proc Natl Acad Sci USA 87: 3014-3017.
20. Peterson D, Milhous W, Wellems T, 1990. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria. Proc Natl Acad Sci USA 87: 3018-3022.
21. Basco L, de Pecoulas P, Wilson C, Le Bras J, Mazabraud A, 1995. Point mutations in the dihydrofolate reductase-thymidylate synthase gene and pyrimethamine and cycloguanil resistance in Plasmodium falciparum. Mol Biochem Parasitol 69: 135-138.
22. Reeder J, Rieckmann K, Genton B, Lorry K, Wines B, Cowman A, 1996. Point mutations in the dihydrofolate reductase and dihydropteroate synthetase genes and in vitro susceptibility to pyrimethamine and cycloguanil of Plasmodium falciparum isolates from Papua New Guinea. Am J Trop Med Hyg 55: 209-213.
23. Viriyakosol S, Siripoon N, Petcharapirat C, Petcharapirat P, Jarra W, Thaithong S, Brown KN, Snounou G, 1995. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bull World Health Organ 73: 85-95.
24. Snewin V, Herrera M, Sanchez G, Scherf A, Langsley G, Herrera S, 1991. Polymorphisms of the alleles of the merozoite surface antigens MSA 1 and MSA 2 in Plasmodium falciparum wild isolates from Columbia. Mol Biochem Parasitol 49: 265-276.
25. Ntoumi F, Contamin H, Rogier C, Bonnefoy S, Trape JF, Mercereau-Puijalon O, 1995. Age-dependent carriage of multiple Plasmodium falciparum merozoite surface antigen-2 alleles in asymptomatic malaria infections. Am J Trop Med Hyg 52: 81-88.
26. Plowe CV, Djimde A, Bouare M, Doumbo O, Wellems TE, 1995. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. Am J Trop Med Hyg 52: 565-568.